Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Biomarin Pharmaceutical Inc (BMRN)  
$88.63 1.44 (1.6%) as of 4:30 Fri 4/19


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 188,370,000
Market Cap: 16.70(B)
Last Volume: 1,778,607 Avg Vol: 1,398,026
52 Week Range: $76.22 - $99
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY     NASDAQ COMPOSITE
    NASDAQ NNM COMPOSITE

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  811
Guru Rank Value     : 0.9
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
Company Profile   BioMarin Pharmaceutical is a biotechnology company that develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Co.'s commercial products are Aldurazyme (laronidase) for Mucopolysaccharidosis I; Brineura (cerliponase alfa) for the treatment of late infantile neuronal ceroid lipofuscinosis type 2; Kuvan (sapropterin dihydrochloride) for the treatment of phenylketonuria; Naglazyme (galsulfase) the treatment of Mucopolysaccharidosis VI ; Palynziq (pegvaliase-pqpz) for adult patients with phenylketonuria; and Vimizim (elosulfase alpha) for the treatment of Mucopolysaccharidosis IV Type A.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 3,625
Total Buy Value $0 $0 $0 $314,469
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 159,588 275,693 319,053 656,089
Total Sell Value $13,270,852 $23,760,160 $27,661,182 $61,420,002
Total People Sold 5 6 7 7
Total Sell Transactions 10 21 27 56
End Date 2024-03-10 2023-12-08 2023-06-09 2022-06-09

   
Records found: 1312
  Page 37 of 53  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Davis George Eric VP, General Counsel   •       –      –    2009-12-02 4 OE $6.13 $153,720 D/D 21,000 41,453     -
   Aselage Steve EVP, Chief Business Officer   •       –      –    2009-10-31 5 B $11.60 $4,119 D/D 355 51,271     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2009-10-31 5 B $11.60 $951 D/D 82 18,584     -
   Wood Mark VP, Human Resources   •       –      –    2009-08-28 4 AS $16.50 $2,921 D/D (177) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2009-08-28 4 OE $6.13 $1,085 D/D 177 8,258     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2009-08-10 4 S $15.69 $31,889 D/D (2,000) 55,440     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2009-08-07 4 S $15.95 $31,902 D/D (2,000) 57,440     -
   Wood Mark VP, Human Resources   •       –      –    2009-07-08 4 S $13.89 $6,333 D/D (456) 8,081     -
   Wood Mark VP, Human Resources   •       –      –    2009-07-07 4 OE $0.00 $0 D/D 1,250 8,537     -
   Wood Mark VP, Human Resources   •       –      –    2009-06-23 4 S $14.75 $5,354 D/D (363) 7,287     -
   Baffi Robert SVP, Technical Operations   •       –      –    2009-06-22 4 OE $0.00 $0 D/D 2,000 53,187     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2009-06-22 4 OE $0.00 $0 D/D 7,500 59,440     -
   Aselage Steve SVP, Chief Business Officer   •       –      –    2009-06-22 4 OE $0.00 $0 D/D 2,500 50,916     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2009-06-22 4 OE $0.00 $0 D/D 2,000 18,502     -
   Wood Mark VP, Human Resources   •       –      –    2009-06-22 4 OE $0.00 $0 D/D 1,000 7,650     -
   Davis George Eric VP, General Counsel   •       –      –    2009-06-22 4 OE $0.00 $0 D/D 1,750 20,453     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2009-06-12 4 B $14.52 $21,780 D/D 1,500 51,940 2.81     -
   Davis George Eric VP, General Counsel   •       –      –    2009-06-11 4 S $14.47 $36,175 D/D (2,500) 16,203     -
   Baffi Robert SVP, Technical Operations   •       –      –    2009-06-07 4 A $0.00 $0 D/D 2,000 51,187     -
   Davis George Eric VP, General Counsel   •       –      –    2009-06-07 4 A $0.00 $0 D/D 1,500 18,703     -
   Aselage Steve SVP, Chief Business Officer   •       –      –    2009-06-07 4 A $0.00 $0 D/D 2,500 48,416     -
   Cooper Jeffrey H SVP, Chief Financial Officer   •       –      –    2009-06-07 4 A $0.00 $0 D/D 2,000 16,502     -
   Bienaime Jean Jacques Chief Executive Officer   •       •      –    2009-06-07 4 A $0.00 $0 D/D 5,000 50,440     -
   Meier Richard A Director   –       •      –    2009-06-05 4 B $13.70 $27,400 D/D 2,000 10,250 2.39     -
   Lawlis V Bryan Director   –       •      –    2009-05-22 4 A $0.00 $0 D/D 2,500 5,000     -

  1312 Records found
  Previous  30  31  32  33  34  35  36  37  38  39  Next   
  Page 37 of 53
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed